|
RBM12 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.94399999992245E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.14510000037704E-07 |
| Normal-vs-Stage2 |
2.013300E-04 |
| Normal-vs-Stage3 |
3.656200E-03 |
| Normal-vs-Stage4 |
1.536330E-03 |
| Stage1-vs-Stage2 |
8.252200E-01 |
| Stage1-vs-Stage3 |
1.679040E-01 |
| Stage1-vs-Stage4 |
8.668200E-01 |
| Stage2-vs-Stage3 |
4.222200E-01 |
| Stage2-vs-Stage4 |
9.984000E-01 |
| Stage3-vs-Stage4 |
5.151200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.92210000005133E-06 |
| Normal-vs-AfricanAmerican |
6.42240000070515E-08 |
| Normal-vs-Asian |
1.586320E-02 |
| Caucasian-vs-AfricanAmerican |
4.057000E-01 |
| Caucasian-vs-Asian |
9.373200E-01 |
| AfricanAmerican-vs-Asian |
8.391800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.90380000231994E-10 |
| Normal-vs-Female |
6.103800E-03 |
| Male-vs-Female |
8.965700E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.50420000011309E-07 |
| Normal-vs-Extreme_Weight |
1.25410000162418E-08 |
| Normal-vs-Obese |
2.779800E-04 |
| Normal-vs-Extreme_Obese |
1.90990999999752E-05 |
| Normal_Weight-vs-Extreme_Weight |
8.792000E-01 |
| Normal_Weight-vs-Obese |
9.847900E-02 |
| Normal_Weight-vs-Extreme_Obese |
4.079000E-01 |
| Extreme_Weight-vs-Obese |
3.820300E-02 |
| Extreme_Weight-vs-Extreme_Obese |
4.771800E-01 |
| Obese-vs-Extreme_Obese |
9.644500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.609200E-01 |
| Normal-vs-Age(41-60Yrs) |
3.9655999999999E-05 |
| Normal-vs-Age(61-80Yrs) |
8.74520000859746E-09 |
| Normal-vs-Age(81-100Yrs) |
1.29999999998187E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.812400E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.081800E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.455800E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.648400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.350100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.125600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.5671999959751E-08 |
| Normal-VS-Type2 PRCC |
3.98970001480592E-09 |
| Normal-VS-KIRP CIMP |
8.412000E-01 |
| Normal-VS-Unclassified PRCC |
1.275850E-02 |
| Type1 PRCC-VS-Type2 PRCC |
2.607600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.118300E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
4.374400E-02 |
| Type2 PRCC-VS-KIRP CIMP |
6.975500E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
9.956200E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
1.807210E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.5338001675741E-10 |
| Normal-vs-N1 |
2.248000E-01 |
| Normal-vs-N2 |
1.409740E-02 |
| N0-vs-N1 |
1.698480E-03 |
| N0-vs-N2 |
8.309200E-01 |
| N1-vs-N2 |
1.988170E-01 |
|
|
